下载掌阅APP，畅读海量书库
立即打开
［1］Alzheimer′s Association Report. 2020 Alzheimer′s disease facts and figures [R/OL].Alzheimer′s & Dementia, 2020, 16 (3): 391-460.
［2］AKPAN A, TABUE-TEGUO M, FOUGÈRE B. Neurocognitive disorders: Importance of early/timely detection in daily clinical practice [J]. Journal of Alzheimer′s Disease, 2019,70 (2): 317-322.
［3］BAYEN E, POSSIN K L, CHEN Y, et al. Prevalence of aging, dementia, and multimorbidity in older adults with Down syndrome [J]. JAMA neurology, 2018, 75 (11): 1399-1406.
［4］COYLE-GILCHRIST I T S, DICK K M, PATTERSON K, et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes [J]. Neurology, 2016, 86 (18): 1736-1743.
［5］DILLEN K N H, JACOBS H I L, KUKOLJA J, et al. Functional disintegration of the default mode network in prodromal Alzheimer’s disease [J]. Journal of Alzheimer′s Disease,2017, 59 (1): 169-187.
［6］HAO L, XING Y, LI X, et al. Risk factors and neuropsychological assessments of subjective cognitive decline (plus) in Chinese memory clinic [J]. Frontiers in Neuroscience, 2019, 13: 846.
［7］HOGAN D B, JETTÉ N, FIEST K M, et al. The prevalence and incidence of frontotemporal dementia: A systematic review [J]. Canadian Journal of Neurological Sciences, 2016,43 (S1): S96-S109.
［8］HUANG Y. Prevalence of mental disorders in China–author′s reply [J]. The Lancet Psychiatry, 2019, 6 (6): 468.
［9］HUANG Y, WANG Y, WANG H, et al. Prevalence of mental disorders in China: A crosssectional epidemiological study [J]. The Lancet Psychiatry, 2019, 6 (3): 211-224.
［10］IMFELD P, BRAUCHLI PERNUS Y B, JICK S S, et al. Epidemiology, co-morbidities, and medication use of patients with Alzheimer′s disease or vascular dementia in the UK [J]. Journal of Alzheimer′s Disease, 2013, 35 (3): 565-573.
［11］ISMAIL Z, AGÜERA-ORTIZ L, BRODATY H, et al. The mild behavioral impairment checklist (MBI-C): A rating scale for neuropsychiatric symptoms in pre-dementia populations [J]. Journal of Alzheimer’s Disease, 2017, 56 (3): 929-938.
［12］ISMAIL Z, SMITH E E, GEDA Y, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment [J]. Alzheimer′s & Dementia: the journal of the Alzheimer′s Association, 2016, 12 (2): 195-202.
［13］JESSEN F, AMARIGLIO R E, BUCKLEY R F, et al. The characterisation of subjective cognitive decline [J]. Lancet Neurol, 2020, 19 (3): 271-278.
［14］JI Y, SHI Z, ZHANG Y, et al. Prevalence of dementia and main subtypes in rural northern china [J]. Dementia and Geriatric Cognitive Disorders, 2015, 39 (5-6): 294-302.
［15］JIA J, WANG F, WEI C, et al. The prevalence of dementia in urban and rural areas of China [J]. Alzheimer′s & Dementia, 2014, 10 (1): 1-9.
［16］JIA L, QUAN M, FU Y, et al. Dementia in China: Epidemiology, clinical management, and research advances [J]. The Lancet Neurology, 2020, 19 (1): 81-92.
［17］KANE J P M, SURENDRANATHAN A, BENTLEY A, et al. Clinical prevalence of Lewy body dementia [J]. Alzheimer′s research & Therapy, 2018, 10 (1): 19.
［18］LIEW T M. Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia [J]. Alzheimer′s & Dementia, 2020, 12 (1): 135.
［19］LOGROSCINO G, PICCININNI M, BINETTI G, et al. Incidence of frontotemporal lobar degeneration in Italy [J]. Neurology, 2019, 92 (20): e2355-e2363.
［20］LUUKKAINEN L, BLOIGU R, MOILANEN V, et al. Epidemiology of frontotemporal lobar degeneration in Northern Finland [J]. Dementia and Geriatric Cognitive Disorders Extra, 2015, 5 (3): 435-441.
［21］MIEBACH L, WOLFSGRUBER S, POLCHER A, et al. Which features of subjective cognitive decline are related to amyloid pathology?Findings from the delcode study [J]. Alzheimer′s research & Therapy, 2019, 11 (1): 66.
［22］NORDENGEN K, KIRSEBOM B-E, HENJUM K, et al. Glial activation and inflammation along the Alzheimer′s disease continuum [J]. Journal of Neuroinflammation, 2019, 16 (1): 46.
［23］O′BRIEN J T, THOMAS A. Vascular dementia [J]. The Lancet, 2015, 386 (10004): 1698-1706.
［24］OHARA T, HATA J, YOSHIDA D, et al. Trends in dementia prevalence, incidence, and survival rate in a Japanese community [J]. Neurology, 2017, 88 (20): 1925-1932.
［25］ONYIKE C U, DIEHL-SCHMID J. The epidemiology of frontotemporal dementia [J]. International Review of Psychiatry (Abingdon, England), 2013, 25 (2): 130-137.
［26］PENDLEBURY S T, ROTHWELL P M, OXFORD VASCULAR S. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: Analysis of the population-based oxford vascular study [J]. Lancet Neurol, 2019, 18 (3): 248-258.
［27］PERROTIN A, DE FLORES R, LAMBERTON F, et al. Hippocampal subfield volumetry and 3D surface mapping in subjective cognitive decline [J]. Journal of Alzheimer′s Disease, 2015, 48 (s1): S141-S150.
［28］PRINCE M, ALI G-C, GUERCHET M, et al. Recent global trends in the prevalence and incidence of dementia, and survival with dementia [J]. Alzheimer′s research &Therapy, 2016, 8 (1): 23.
［29］RABIN L A, SMART C M, AMARIGLIO R E. Subjective cognitive decline in preclinical Alzheimer′s disease [J]. Annual Review of Clinical Psychology, 2017, 13 (1): 369-396.
［30］RAJAN K B, WEUVE J, BARNES L L, et al. Prevalence and incidence of clinically diagnosed Alzheimer′s disease dementia from 1994 to 2012 in a population study [J].Alzheimer′s & Dementia: the journal of the Alzheimer′s Association, 2019, 15 (1): 1-7.
［31］RIZZI L, ROSSET I, RORIZ-CRUZ M. Global epidemiology of dementia: Alzheimer′s and vascular types [J/OL]. (2014-6-25)[2020-12-15]. https://doi. org/10. 1155/2014/908915.
［32］RUBENSTEIN E, HARTLEY S, BISHOP L. Epidemiology of dementia and Alzheimer disease in individuals with Down syndrome [J]. JAMA neurology, 2020, 77 (2): 262-264.
［33］SAVICA R, GROSSARDT B R, BOWER J H, et al. Incidence of dementia with Lewy bodies and Parkinson disease dementia [J]. JAMA neurology, 2013, 70 (11): 1396-1402.
［34］THOMAS K R, OSUNA J R, WEIGAND A J, et al. Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline [J]. Journal of cerebral blood flow and metabolism, 2021, 41 (5): 1001-1012.
［35］WANG H, XIE H, QU Q, et al. The continuum of care for dementia: Needs, resources and practice in China [J]. Journal of Global Health, 2019, 9 (2): 020321.
［36］YANG L, JIN X, YAN J, et al. Prevalence of dementia, cognitive status and associated risk factors among elderly of Zhejiang province, China in 2014 [J]. Age and Ageing, 2016, 45 (5): 707-710.
［37］YANG S K, CHEN W, SU C H, et al. Incidence and comorbidity of dementia with Lewy bodies: A population-based cohort study [J/OL]. Behavioural Neurology.(2018-5-29)[2020-12-18]. https://doi. org/10.1155/2018/7631951.
［38］YUE W, WANG X D, SHI Z, et al. The prevalence of dementia with Lewy bodies in a rural area of China [J]. Parkinsonism & Related Disorders, 2016 (29): 72-77.
［39］ZAHIROVIC I, TORISSON G, WATTMO C, et al. Survival among the older adults with clinical signs of Lewy body dementia in 40 Swedish nursing homes: A 6-year follow-up study [J]. BMJ Open, 2019, 9 (5): e028010.
［40］ZHANG H, LOI S M, ZHOU S A, et al. Dementia literacy among communitydwelling older adults in urban China: A cross-sectional study [J]. Frontiers in Public Health, 2017, 5: 124.
［41］ZHAO M, LV X, TUERXUN M, et al. Delayed help seeking behavior in dementia care: Preliminary findings from the clinical pathway for Alzheimer′s disease in China (CPAD) study [J]. International Psychogeriatrics, 2016, 28 (2): 211-219.
［42］ROEHR B. American psychiatric association explains DSM-5 [J]. BMJ, 2013, 346: f3591.
［43］刘伯源，王久玲，肖义泽．中国60岁及以上人群老年期痴呆患病率meta分析[J]．中华流行病学杂志，2016，37 (11)：1541-1545．
［44］国务院办公厅关于印发健康中国行动组织实施和考核方案的通知：国办发〔2019〕32号[A/OL]．(2019-6-24)[2020-12-20]．http://www.gov.cn/zhengce/content/2019-07/15/content_5409499.htm.